Showing results (1871-1880 of 2,316) with videos related to

Sort By:
Pageof 232
ACS Nano|February 4, 2025
Breakdown of the Static Dielectric Screening Approximation of Coulomb Interactions in Atomically Thin SemiconductorsAmine Ben Mhenni, Dinh Van Tuan, Leonard Geilen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedulesA B Simpson, P M Calvert, J A Sludden, et al.
The Oncologist|September 13, 2021
Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation BrachytherapyMatthew N Mills, Nicholas W Russo, Matthew Fahey, et al.
Annals of Emergency Medicine|November 19, 2022
A Quality Measurement Framework for Emergency Department Care of Psychiatric EmergenciesDana D Im, Kirstin W Scott, Arjun K Venkatesh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2015
Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource OptimizationCliff C Kerr, Robyn M Stuart, Richard T Gray, et al.
Immunogenetics|March 26, 2009
Trans-species polymorphism of the Mhc class II DRB-like gene in banded penguins (genus Spheniscus)Eri F Kikkawa, Tomi T Tsuda, Daisuke Sumiyama, et al.
Science Translational Medicine|December 7, 2021
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individualsMarie I Samanovic, Amber R Cornelius, Sophie L Gray-Gaillard, et al.
Gut|December 15, 2000
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisC D Johnson, A N Kingsnorth, C W Imrie, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumonLoes E Visser, Fernie J A Penning-van Beest, J H P Wilson, et al.
BMJ Open|June 3, 2019
Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationaleMarina Mutter, Melissa Martin, Yu Yamamoto, et al.
Pageof 232